Cargando…
Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
BACKGROUND: Oral tacrolimus is a therapeutic agent for moderate to severe steroid-dependent or resistant ulcerative colitis (UC), but remission induction is difficult, and it is necessary to treat the patient while considering the next treatment. AIM: To examine serum albumin (Alb) level as a progno...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192282/ https://www.ncbi.nlm.nih.gov/pubmed/34168412 http://dx.doi.org/10.3748/wjg.v27.i22.3109 |